The PI3K/Akt pathway (He et al., 2021), famous for its essential role in regulating cell survival, proliferation, and metabolism, has been extensively investigated in diverse diseases, such as cancer (Chawra et al., 2024), inflammation (He et al., 2022), and metabolic disorders (Huang et al., 2018). This evidence concerns the gene AKT1 and metabolic disease.